Used in research for cancer treatment, particularly in inhibiting aurora kinases and VEGFR2, which are involved in cell division and tumor blood vessel formation. Shows potential in targeting resistant cancer cells and reducing tumor growth in preclinical models. Investigated for use in breast and colorectal cancers due to its dual inhibition properties. Still under study, not approved for clinical use.